Skip to main content

Life Tech Provides SOLiD Platform for University of Strasbourg's Genomax Project


Life Technologies said last month that its SOLiD platform is "supporting" the Genomax project of the University of Strasbourg, France, to study diseases such as diabetes, obesity, asthma, and arterial hypertension.

Genomax, funded with €1.1 million ($1.4 million) from the University of Strasbourg, the regional government, and others, is part of Biomax, a translational biobank project to enable the storage and analysis of thousands of human samples.

According to Seiamak Bahram, head of Genomax and a professor of immunology at Strasbourg University Hospital, "hundreds" of blood samples have been sequenced on the SOLiD platform, providing "an invaluable insight into the most common diseases."

Life Tech's director of digital PCR in Europe, Herve Pouzoullic, said in a statement that the company "is proud to be supplying" its products to Genomax, including its SOLiD sequencing and Open Array Real-Time PCR platforms.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.